IBanga Lezemithi 1377049-84-7 I-Velpatasvir Yokwelapha I-Hepatitis C
Umkhiqizoigama | I-Velpatasvir |
Omqondofana | I-GS 5816;I-Methyl [(2S)-1-[(2S,5S)-2-[9-[2-[(2S,4S))-1-[(2R)-2-[(methoxycarbonyl)amino]-2-phenylacetyl] -4-(methoxymethyl)pyrrolidin-2-yl]-1H-imidazol-5-yl]-1,11-dihydroisochromeno[4',3':6,7]naphtho[1,2-d]imidazol-2- yl]-5-methylpyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate |
Inombolo ye-CAS. | 1377049-84-7 |
Ukubukeka | Impushana emhlophe ukuya kokuphuzi |
I-Molecular Formula | C49H54N8O8 |
Isisindo samangqamuzana | 883.00 |
Ukusetshenziswa | Ibanga Lezemithi noma inhloso yocwaningo |
Ukupakisha | Njengesicelo sakho |
Isitoreji | Londoloza ezitsheni eziqinile, ezimelana nokukhanya endaweni epholile |
I-Velpatasvir Cas: 1377049-84-7 | ||
Izinto | Okujwayelekile | Imiphumela |
Ukubukeka | Impushana emhlophe ukuya kokuphuzi | Impushana ephuzi ekhanyayo |
Ukuhlonza | I-HPLCIR | Iyahambisana |
Izinto Ezihlobene | Noma yikuphi okunye ukungcola ≤0.5%Ukungcola Okuphelele ≤1.0% | 0.15%0.87% |
Amanzi(KF) | I-NMT 3.0% | 2.1% |
Izincibilikisi Ezisele | Ihlangabezana nezimfuneko zamanje ze-ICH | Iyahambisana |
Izinsalela ekushiseni | I-NMT 0.2% | Iyahambisana |
Izinsimbi Ezisindayo | I-NMT 20ppm | Iyahambisana |
Isivivinyo (kusekelwe ku-anhydrous) | 98.0%~102.0% | 98.9% |
Isiphetho:ihambisana namazinga angaphakathi endlini |
Ulwazi Lwenkampani
√ Isipiliyoni esigcwele se-Management layer kubalandeli befektri nabanekhono; √ Ikhwalithi ihlale iwukucatshangelwa kwethu okuphezulu, uhlelo oluqinile lwe-QC; √ Ithimba leminyaka engu-11 elinesipiliyoni sokuthumela ngaphandle; √ Ilebhu ye-R&D ezimele; √ Izinkundla zokucobelelana ngolwazi ezimbili ze-GMP zesikhathi eside ezisayiniwe; √ Izinsiza ezicebile zamafekthri amaningi angasebenzi wephrojekthi eyenziwe ngokwezifiso; √ Ithimba elisebenzayo elisebenza kahle elinendlela engaguquki.Bhala umyalezo wakho lapha futhi usithumelele wona